Paolo Fraticelli Selected Research

Systemic Scleroderma (Systemic Sclerosis)

2/2020	The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements.
7/2018	Combination therapy with rituximab and mycophenolate mofetil in systemic sclerosis. A single-centre case series study.
9/2017	A novel iloprost administration method with portable syringe pump for the treatment of acral ulcers and Raynaud's phenomenon in systemic sclerosis patients. A pilot study (ILOPORTA).
7/2015	Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab.
7/2014	Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.
6/2006	Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Fraticelli Research Topics

Disease

9	Vasculitis (Vasculitides) 12/2023 - 09/2015
6	Churg-Strauss Syndrome (Allergic Angiitis) 12/2023 - 01/2021
6	Systemic Scleroderma (Systemic Sclerosis) 02/2020 - 06/2006
3	Cryoglobulinemia 02/2023 - 01/2021
3	Fibrosis (Cirrhosis) 01/2020 - 07/2015
3	Multiple Myeloma 12/2012 - 06/2010
2	Asthma (Bronchial Asthma) 12/2023 - 12/2023
2	Systemic Vasculitis 04/2023 - 06/2021
2	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 06/2006
2	Infections 09/2015 - 05/2011
1	Eosinophilia 12/2023
1	Inflammation (Inflammations) 01/2023
1	Vascular Skin Diseases 01/2023
1	Hepatitis B 06/2021
1	Rheumatoid Arthritis 01/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021
1	Disease Progression 02/2020
1	Dyspepsia (Indigestion) 01/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019
1	digital ulcers 09/2017
1	Splenomegaly 03/2017
1	Purpura 03/2017
1	Sjogren's Syndrome (Sjogren Syndrome) 03/2017
1	Lymphadenopathy 03/2017
1	Fatigue 03/2017
1	Arthralgia (Joint Pain) 03/2017
1	Chronic Hepatitis (Chronic Active Hepatitis) 12/2016
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 10/2016
1	Agammaglobulinemia (Hypogammaglobulinemia) 09/2015
1	Pain (Aches) 01/2015
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2014
1	Skin Manifestations 05/2012
1	Neoplasms (Cancer) 05/2011
1	Pneumonia (Pneumonitis) 05/2011

Drug/Important Bio-Agent (IBA)

7	Rituximab (Mabthera)FDA Link 02/2023 - 07/2015
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2023 - 05/2012
3	Prednisone (Sone)FDA LinkGeneric 12/2023 - 01/2022
2	dupilumabIBA 12/2023 - 01/2023
2	benralizumabIBA 12/2023 - 01/2023
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2023 - 02/2023
2	CryoglobulinsIBA 02/2023 - 03/2017
2	mepolizumabIBA 01/2023 - 01/2022
2	AutoantibodiesIBA 06/2021 - 06/2006
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2018 - 12/2016
2	Imatinib Mesylate (Gleevec)FDA Link 10/2016 - 07/2014
1	GlucocorticoidsIBA 12/2023
1	Interleukin-5 (Interleukin 5)IBA 12/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2021
1	AntibodiesIBA 06/2021
1	Immunoglobulin A (IgA)IBA 06/2021
1	Complement System Proteins (Complement)IBA 06/2021
1	VaccinesIBA 03/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	CT-P10IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 02/2020
1	BilirubinIBA 01/2020
1	GastrinsIBA 01/2019
1	Chromogranin AIBA 01/2019
1	Proton Pump InhibitorsIBA 01/2019
1	Carbon MonoxideIBA 07/2018
1	Iloprost (Ventavis)FDA Link 09/2017
1	Rheumatoid FactorIBA 03/2017
1	Collagen Type I (Type I Collagen)IBA 07/2015
1	Analgesics (Analgesic Drugs)IBA 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2014
1	Drug CombinationsIBA 05/2011
1	Thalidomide (Thalomid)FDA Link 05/2011
1	Immunoglobulin G (IgG)IBA 06/2006
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 06/2006

Therapy/Procedure

7	Therapeutics 12/2023 - 06/2010
1	Retreatment 09/2015
1	Antibiotic Prophylaxis 05/2011
1	Stem Cell Transplantation 06/2010